Lipoprotein(a): The bad cholesterolHABIB, Syed S.Saudi medical journal. 2004, Vol 25, Num 4, pp 429-433, issn 0379-5284, 5 p.Article

Lipoprotein(a) metabolism: Potential sites for therapeutic targetsHOOVER-PLOW, Jane; MENGGUI HUANG.Metabolism, clinical and experimental. 2013, Vol 62, Num 4, pp 479-491, issn 0026-0495, 13 p.Article

Lipoprotein(a) is a potent chemoattractant for human peripheral monocytesSYROVETS, T; THILLET, J; CHAPMAN, M. J et al.Blood. 1997, Vol 90, Num 5, pp 2027-2036, issn 0006-4971Article

Lp(a) phenotype in cardiovascular disease: Elevated lipoprotein(a) phenotype F in a family with hypertension and a history of stroke and heart disease, but with low plasma cholesterolLINDSEY, Saralyn; PETRAS, Stephen F; CLARK, Ronald W et al.Recent research developments in lipids. Vol. 4 (2000) ; Part I. Recent research developments in lipids. 2000, pp 83-97, isbn 81-86846-62-XBook Chapter

Metabolism of Lp(a) : assembly and excretionKOSTNER, G. M; XINGDE WO; FRANK, S et al.Clinical genetics. 1997, Vol 52, Num 5, pp 347-354, issn 0009-9163Conference Paper

Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertensionANTONICELLI, R; TESTA, R; BONFIGLI, A. R et al.Clinical and experimental medicine (Testo stampato). 2001, Vol 1, Num 3, pp 145-150, issn 1591-8890, 6 p.Article

Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1FERRETTI, G; BACCHETTI, T; CAMPANATI, A et al.British journal of dermatology (1951). 2012, Vol 166, Num 1, pp 204-207, issn 0007-0963, 4 p.Article

Lipoprotein(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi populationHABIB, Syed S; ABDEL-GADER, Abdel-Galil M; KURDI, Mohammad I et al.Saudi medical journal. 2009, Vol 30, Num 3, pp 346-352, issn 0379-5284, 7 p.Article

Niacin and Lipoprotein(a) : Facts, Uncertainties, and Clinical ConsiderationsSCANU, Angelo M; BAMBA, Ravi.The American journal of cardiology. 2008, Vol 101, Num 8A, issn 0002-9149, 44B-47B, SUPArticle

Lp(a) lipoprotein: Coping with heterogeneitySCANU, Angelo M.The New England journal of medicine. 2003, Vol 349, Num 22, pp 2089-2090, issn 0028-4793, 2 p.Article

Effects of exercise on lipoprotein(a)MACKINNON, L. T; HUBINGER, L. M.Sports medicine (Auckland). 1999, Vol 28, Num 1, pp 11-24, issn 0112-1642Article

Analysis of the mechanism of lipoprotein(a) assemblyKOSCHINSKY, M. L; MARCOVINA, S. M; MAY, L. F et al.Clinical genetics. 1997, Vol 52, Num 5, pp 338-346, issn 0009-9163Conference Paper

Lipoprotein(a) : identification of subjects with a superbinding capacity for fibrinogenSCANU, A. M; ATZENI, M. M; EDELSTEIN, C et al.Clinical genetics. 1997, Vol 52, Num 5, pp 367-370, issn 0009-9163Conference Paper

Standardization of Lp(a) measurementsKOSTNER, G. M; STEINMETZ, A.Clinical genetics. 1997, Vol 52, Num 5, pp 393-397, issn 0009-9163Conference Paper

High lipoprotein(a) serum levels in three CADASIL familiesVALENTI, Raffaella; NANNUCCI, Serena; PESCINI, Francesca et al.Journal of neurology. 2012, Vol 259, Num 2, pp 379-380, issn 0340-5354, 2 p.Article

Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantationKRONENBERG, Florian; LHOTTA, Karl; KÖNIG, Paul et al.European journal of human genetics. 2003, Vol 11, Num 9, pp 693-699, issn 1018-4813, 7 p.Article

Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a)RAINWATER, D. L; KAMMERER, C. M; VANDEBERG, J. L et al.Atherosclerosis. 1997, Vol 128, Num 2, pp 223-233, issn 0021-9150Conference Paper

Soy Protein Effects on Serum Lipoproteins: A Quality Assessment and Meta-Analysis of Randomized, Controlled StudiesANDERSON, James W; BUSH, Heather M.Journal of the American College of Nutrition. 2011, Vol 30, Num 2, pp 79-91, issn 0731-5724, 13 p.Article

Impact of markedly elevated serum lipoprotein(a) levels (>100 mg/dL) on the risk of coronary heart diseaseMURASE, Toshio; OKUBO, Minoru; AMEMIYA-KUDO, Michiyo et al.Metabolism, clinical and experimental. 2007, Vol 56, Num 9, pp 1187-1191, issn 0026-0495, 5 p.Article

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds : A meta-analysis of randomized controlled trialsBIRJMOHUN, Rakesh S; HUTTEN, Barbara A; KASTELEIN, John J. P et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 2, pp 185-197, issn 0735-1097, 13 p.Article

Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart ProjectTAVRIDOU, A; UNWIN, N; BHOPAL, R et al.European journal of clinical investigation. 2003, Vol 33, Num 8, pp 686-692, issn 0014-2972, 7 p.Article

Lp(a) lipoprotein, vascular disease, and mortality in the elderlyARIYO, Abraham A; THACH, Chau; TRACY, Russell et al.The New England journal of medicine. 2003, Vol 349, Num 22, pp 2108-2115, issn 0028-4793, 8 p.Article

Identification of apo(a) phenotypes in a Korean population using a standardized nomenclature system based on the number of kringle IV repeatsMIN, W.-K; JAE OK LEE; CHUN HEE KIM et al.Annals of clinical biochemistry. 1997, Vol 34, pp 681-687, issn 0004-5632, 6Article

Expérience du dosage de la lipoprotéine (a) dans une population marocaine de 184 sujets = Experience of lipoprotein (a) dosage in 184 moroccan subjectsFELLAT, S; LAHFIDI, K; SRAÏRI, J.-E et al.Archives des maladies du coeur et des vaisseaux. 1997, Vol 90, Num 10, pp 1371-1376, issn 0003-9683Article

Biogenesis of Lp(a) in transgenic mouse hepatocytesWHITE, A. L.Clinical genetics. 1997, Vol 52, Num 5, pp 326-337, issn 0009-9163Conference Paper